Saturday 20 October 2018
Contact US    |    Archive
Reuters
30 days ago

Bayer hemophilia treatment wins thumbs-up from EU panel

Bayer AG s long-acting treatment for hemophilia A has won a recommendation from a European Medicines Agency (EMA) panel for the treatment of the rare genetic disorder in which blood does not clot easily.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

Bayer

 | 

hemophilia

 | 

treatment

 | 

wins

 | 

thumbs

 | 

from

 | 

panel

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)